Molecular and Cellular Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California, USA.
1] Institut Curie, Centre de Recherche, Paris, France. [2] Centre National de la Recherche Scientifique, Paris, France. [3].
Nat Struct Mol Biol. 2014 Feb;21(2):167-74. doi: 10.1038/nsmb.2754. Epub 2014 Jan 12.
The mechanism of activation of the alternative lengthening of telomeres (ALT) pathway of mammalian chromosome-end maintenance has been unclear. We have now discovered that co-depletion of the histone chaperones ASF1a and ASF1b in human cells induced all hallmarks of ALT in both primary and cancer cells. These included the formation of ALT-associated PML (promyelocytic leukemia) bodies (APBs), the presence of extrachromosomal telomeric DNA species, an elevated frequency of telomeric sister chromatid exchanges (t-SCE) events and intertelomeric exchange of an integrated tag. The induction of ALT characteristics in this setting led to the simultaneous suppression of telomerase. We determined that ALT induction is positively regulated by the proteins RAD17 and BLM and negatively regulated by EXO1 and DNA2. The induction of ALT phenotypes as a consequence of ASF1 depletion strongly supports the hypothesis that ALT is a consequence of histone management dysfunction.
哺乳动物染色体末端维持的端粒延长替代途径(ALT)的激活机制尚不清楚。我们现在发现,在人类细胞中同时耗尽组蛋白伴侣 ASF1a 和 ASF1b 会在原代细胞和癌细胞中诱导 ALT 的所有特征。这些特征包括 ALT 相关的早幼粒细胞白血病体(PML)的形成(APBs),存在染色体外端粒 DNA 物种,端粒姐妹染色单体交换(t-SCE)事件的频率升高,以及整合标签的端粒间交换。在这种情况下,ALT 特征的诱导导致端粒酶的同时抑制。我们确定,RAD17 和 BLM 蛋白正向调节 ALT 的诱导,而 EXO1 和 DNA2 负向调节。ASF1 耗竭导致 ALT 表型的诱导强烈支持这样的假设,即 ALT 是组蛋白管理功能障碍的结果。
Nat Struct Mol Biol. 2014-1-12
Genes (Basel). 2020-3-13
Mol Cancer Res. 2013-3-15
Nucleic Acids Res. 2024-6-24
J Transl Med. 2025-8-14
Nucleic Acids Res. 2025-8-11
Cell Biosci. 2025-3-1
Nature. 2012-10-17